Innovotech Inc
XTSX:IOT

Watchlist Manager
Innovotech Inc Logo
Innovotech Inc
XTSX:IOT
Watchlist
Price: 0.165 CAD -2.94%
Market Cap: 6.7m CAD
Have any thoughts about
Innovotech Inc?
Write Note

Innovotech Inc
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Innovotech Inc
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Innovotech Inc
XTSX:IOT
Note Receivable
CA$330k
CAGR 3-Years
40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abcellera Biologics Inc
NASDAQ:ABCL
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Note Receivable
CA$133.6k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Innovotech Inc
Glance View

Market Cap
6.4m CAD
Industry
Life Sciences Tools & Services

Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States and internationally. The company is headquartered in Edmonton, Alberta. The company went IPO on 2003-05-28. The firm's contract research services cover various applications, including implanted devices antimicrobial testing; antibiotic and biocide efficacy screening; agricultural diseases, food safety; dental biofilms; waterline and pipeline fouling; regulatory submission packages; consulting services; and third-party validations. The firm's assays and services include biofilm antimicrobial testing, planktonic antimicrobial testing, aerobic and anaerobic microorganisms as well as bacterial spores. Its products include InnovoSIL Antimicrobial Products, The MBEC Assay, and Agress and AgreGuard. InnovoSIL is a family of antimicrobial agents suited to coating onto or incorporation into medical devices. The MBEC assay is biofilm growth device. Agress and AgreGuard is a seed treatment and plant spray.

IOT Intrinsic Value
0.068 CAD
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Innovotech Inc's Note Receivable?
Note Receivable
330k CAD

Based on the financial report for Jun 30, 2024, Innovotech Inc's Note Receivable amounts to 330k CAD.

What is Innovotech Inc's Note Receivable growth rate?
Note Receivable CAGR 3Y
40%

Over the last year, the Note Receivable growth was 57%. The average annual Note Receivable growth rates for Innovotech Inc have been 40% over the past three years .

Back to Top